Antibiotice Sa · BVB:ATB
Antibiotice Sa — H1 2025 Earnings Presentation
15 slides from Antibiotice Sa's earnings presentation, Aug 21, 2025
Slide 1: 70 years of trust, performance and sustainable partnerships
70 years of trust, performance and sustainable partnerships www.antibiotice.ro
Slide 2: Main results recorded in Semester I of 2025
Write it here Main results recorded in Semester I of 2025 380.16 138 mill. lei 26% 4th place mill. lei total income of consolidated 4th place in terms of the gross profit cumulated the sales in international 380.16 million lei boxed consumption on the with the value of the claw- markets were worth 1
Slide 3: A performance-oriented company
Write it here A performance-oriented company Symbol ATB Pension funds Privately managed funds Market Main 13.83% Listing date April 16, 1997 Ministry of Health Capitalization 1.63 billion lei* 53.02% Individuals Nominal value 0.10 lei/share Shareholder structure 16.98% Number of shares 671,338,040 S
Slide 4: Antibiotice – a company worth working for
Write it here Antibiotice – a company worth working for Professionals with secondary education Higher education specialists (53% - 722) (47% - 647) 1369 EMPLOYEES Secondary education staff - 47% of employees Top professions Higher education specialists - 53% of employees Operator site produse farmac
Slide 5: Antibiotice – a company oriented towards knowledge and performance
Write it here Antibiotice – a company oriented towards knowledge and A+ TECHNICAL performance A+ BUSINESS COLLEGE SCHOOL PREUNIVERSITY ENVIRONMENT UNIVERSITY ENVIRONMENT Professional internships Internships and career guidance ❑ Internships for students pursuing qualifications of interest to ❑ Inter
Slide 6: Antibiotice – In the service of life for a lifetime
Semester I 2025 > 500 marketing authorizations in 42 countries Antibiotice – In the service of life for a Write it here 11 therapeutic classes 25 critical molecules lifetime 50 critical products 5 new products in S1-2025 Oral Solid Topical Active Forms Forms Sterile Substances Division Division Prod
Slide 7: Antibiotice – on the Romanian pharmaceutical market
Write it here Antibiotice – on the Romanian pharmaceutical market In the first half of 2025 on the domestic market, Antibiotice S.A.: maintains its 4th place is the value leader in the (out of a total of 371 segment of generic companies) in medicines sold in hospitals, consumption (boxes) in with a
Slide 8: Antibiotice – an international brand
Antibiotice – an international brand Write it here Europe 50% Asia & Australia 28% Americas 17% Middle East & Africa 5% Marketing and Sales Representatives/Dealers World leader in the North America (USA, Canada) 4 business representative offices: production of the Republic of Moldova South America (
Slide 9: Antibiotice – an internationally recognized Romanian brand
Antibiotice – an internationally recognized Romanian brand Write it here Turnover on international markets 138 million lei Through the Nystatin active ingredient range, Antibiotice has consolidated its leading position on the global market. Progress has been made in development projects in South Ame
Slide 10: Applying business consolidation principles
Applying business consolidation principles It. Method of 30 June 2025/ Write it here Indicators 30 June 2025 30 June 2024 no. calculation 30 June 2024 Income from contracts with customers (turnover) + 1 1=2+3+4 Changes in stocks of finished goods and work in 369,596,913 374,523,913 -1% progress + In
Slide 11: Aplicarea principiilor de consolidare a afacerii
Aplicarea principiilor de consolidare a afacerii Write it here It. Method of 30 June 2025/ Indicators 30 June 2025 30 June 2024 no. calculation 30 June 2024 1 Current assets 627,385,321 512,268,956 22% 2 Cash and cash equivalents 10,352,996 60,754,738 -83% 3 Short-term bank debt 106,338,744 27,329,0
Slide 12: Implementation of the investment plan for Semester I 2025
Write it here Implementation of the investment plan for Semester I 2025 Total investments: 27.55 million lei • development of the product portfolio • adaptation to development trends of the through own research: 5.09 million lei; industrial platform, utility supply and distribution infrastructure, s
Slide 13: The project INOVA a+ Research and Development Center and Critical Medicine Production
The project"INOVA a+ Research and Development Center and Critical Medicine Write it here Production" Inova a+ size: Built area: 2,422.30 m² Developed built area: 6733,40 m² Proposed area for green areas: 127.75 m² Total estimated value of the Euro Lei project(eligible + ineligible), Funder: MIPE 75,
Slide 14: Antibiotice – a friendly and responsible brand
Write it here Antibiotice – a friendly and responsible brand Corporate social responsibility • “Donate blood! Put some • The "Education in Action" heart for life” – blood project, beneficiaries - 254 donation campaign – students from high schools in Iasi, employed donors and co-financed by the Europ
Slide 15: www.antibiotice.ro
Antibiotice Stiinta si suflet www.antibiotice.ro